Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Sarah J. Conley(University of Michigan–Ann Arbor), Max S. Wicha(Michigan United)
Cited by 666
Related Papers
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
|Journal of Clinical Investigation|2010|738
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
|Journal of Clinical Investigation|2011|608
Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
|PLoS Biology|2009|525
Mammary stem cells, self-renewal pathways, and carcinogenesis
|Breast Cancer Research|2005|443
Survival of Mammary Stem Cells in Suspension Culture: Implications for Stem Cell Biology and Neoplasia
|Journal of Mammary Gland Biology and Neoplasia|2005|194